HomeENVB • NASDAQ
Enveric Biosciences Inc
Follow
$1.15
4.96%
Pre-market:(1.73%)-0.020
$1.13
Closed: Apr 8, 8:12:47 AM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.17M | 33.11% |
Net income | -3.15M | 8.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.09M | -34.42% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.24M | -2.05% |
Total assets | 3.08M | -28.31% |
Total liabilities | 1.49M | -36.43% |
Total equity | 1.59M | — |
Shares outstanding | 2.47M | — |
Price to book | 0.51 | — |
Return on assets | -201.57% | — |
Return on capital | -286.24% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.15M | 8.19% |
Cash from operations | -1.31M | 25.10% |
Cash from investing | — | — |
Cash from financing | 463.45K | 349.05% |
Net change in cash | -870.66K | 56.00% |
Free cash flow | -35.15K | 98.66% |
Previous close
$1.21
Day range
$1.10 - $1.24
Year range
$1.10 - $15.45
Market cap
2.84M USD
Avg Volume
5.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1994
Headquarters
Website
Employees
6
